子宫癌肉瘤2例临床病理特征分析并文献复习
Analysis of Clinicopathological Features of Two Cases of Uterine Carcinosarcoma with a Literature Review
摘要: 目的:探讨子宫癌肉瘤的临床病理学特征;方法:回顾性分析2023年华北理工大学附属医院2例子宫癌肉瘤,分析其临床及病理学资料并文献复习。结果:肿瘤显示双向分化,即由恶性上皮成分和肉瘤样成分2种成分构成,两者或分界清楚或穿插移行。上皮成分均为浆液性癌,肉瘤成分为横纹肌肉瘤、软骨肉瘤或平滑肌肉瘤。上皮成分均表达CK,肉瘤成分表达Vimentin,横纹肌肉瘤表达MyoD1、Myoglobin,软骨肉瘤表达S100,平滑肌肉瘤表达SMA、Desmin、Caldesmon;结论:子宫癌肉瘤预后差,确诊需结合组织形态学、免疫表型或分子表型综合分析,预后与癌的组织学类型、肉瘤样成分的比例及肿瘤分期有关。
Abstract: Objective: To investigate the clinicopathological features of uterine carcinosarcoma. Methods: Two cases of uterine carcinosarcoma in the Affiliated Hospital of North China University of Science and Technology in 2023 were retrospectively analyzed, and their clinical and pathological data were analyzed and literature reviewed. Results: The tumor showed bidirectional differentiation, that is, it was composed of two components, the malignant epithelial component and the sarcomatoid component, and the two were either clearly demarcated or interspersed with migration. The epithelial components are all serous carcinomas, and the sarcoma components are rhabdomyosarcoma, chondrosarcoma, or leiomyosarcoma. The epithelial components expressed CK, the sarcoma components expressed Vimentin, the rhabdomyosarcoma expressed MyoD1 and Myoglobin, the chondrosarcoma expressed S100, and the leiomyosarcoma expressed SMA, Desmin and Caldesmon. Conclusion: Uterine carcinosarcoma has a poor prognosis, and diagnosis requires a comprehensive analysis of tissue morphology, immune phenotype, or molecular phenotype. The prognosis is related to the histological type of cancer, the proportion of sarcomatoid components and the tumor stage.
文章引用:张可心, 王琦, 罗丹, 唐慧, 宋旭东. 子宫癌肉瘤2例临床病理特征分析并文献复习[J]. 临床医学进展, 2024, 14(12): 1043-1048. https://doi.org/10.12677/acm.2024.14123183

参考文献

[1] Sagebiel, T.L., Bhosale, P.R., Patnana, M., Faria, S.C. and Devine, C.E. (2019) Uterine Carcinosarcomas. Seminars in Ultrasound, CT and MRI, 40, 295-301. [Google Scholar] [CrossRef] [PubMed]
[2] Pezzicoli, G., Moscaritolo, F., Silvestris, E., Silvestris, F., Cormio, G., Porta, C., et al. (2021) Uterine Carcinosarcoma: An Overview. Critical Reviews in Oncology/Hematology, 163, Article ID: 103369. [Google Scholar] [CrossRef] [PubMed]
[3] 胡萍萍, 许跃, 陈淼, 等. 子宫内膜癌肉瘤9例临床病理分析[J]. 诊断病理学杂志, 2016, 23(4): 279-282.
[4] 孙森森, 刘盈盈, 吕荣荣, 等. 输卵管癌肉瘤合并子宫内膜癌一例并文献复习[J]. 国际妇产科学杂志, 2021, 48(2): 165-168.
[5] Capilna, M. and Cozlea, A. (2021) 1102 Carcinosarcoma of the Fallopian Tube: A Case Report and Review of the Literature. International Journal of Gynecologic Cancer, 31, A172. [Google Scholar] [CrossRef
[6] Toboni, M.D., Crane, E.K., Brown, J., Shushkevich, A., Chiang, S., Slomovitz, B.M., et al. (2021) Uterine Carcinosarcomas: From Pathology to Practice. Gynecologic Oncology, 162, 235-241. [Google Scholar] [CrossRef] [PubMed]
[7] 吴林林, 白杨, 胡艳萍. 子宫癌肉瘤临床病理特征及分子分型[J]. 中国妇产科临床杂志, 2022, 23(1): 67-68.
[8] Artioli, G., Wabersich, J., Ludwig, K., Gardiman, M.P., Borgato, L. and Garbin, F. (2015) Rare Uterine Cancer: Carcinosarcomas. Review from Histology to Treatment. Critical Reviews in Oncology/Hematology, 94, 98-104. [Google Scholar] [CrossRef] [PubMed]
[9] Matsuzaki, S., Klar, M., Matsuzaki, S., Roman, L.D., Sood, A.K. and Matsuo, K. (2021) Uterine Carcinosarcoma: Contemporary Clinical Summary, Molecular Updates, and Future Research Opportunity. Gynecologic Oncology, 160, 586-601. [Google Scholar] [CrossRef] [PubMed]
[10] Versluis, M.A.C., Pielsticker, C., van der Aa, M.A., de Bruyn, M., Hollema, H. and Nijman, H.W. (2018) Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study. Oncology, 95, 100-108. [Google Scholar] [CrossRef] [PubMed]
[11] Sozen, H., Çiftçi, R., Vatansever, D., Topuz, S., Iyibozkurt, A.C., Bozbey, H.U., et al. (2016) Combination of Adjuvant Chemotherapy and Radiotherapy Is Associated with Improved Survival at Early Stage Type II Endometrial Cancer and Carcinosarcoma. Australian and New Zealand Journal of Obstetrics and Gynaecology, 56, 199-206. [Google Scholar] [CrossRef] [PubMed]
[12] 李灿, 李慧, 程静新. 绝经后子宫内膜增厚与子宫内膜病变的相关性研究[J]. 实用妇产科杂志, 2021, 37(1): 62-66.
[13] Zhao, F., Tan, P., Wang, C., Ji, X. and Chen, A. (2021) Effect of Adjuvant Therapy on the Prognosis in Stage I/II Uterine Carcinosarcoma: A Meta‐Analysis. Journal of Obstetrics and Gynaecology Research, 47, 2473-2480. [Google Scholar] [CrossRef] [PubMed]
[14] Li, L., Huang, W., Xue, K., Feng, L., Han, Y., Wang, R., et al. (2021) Clinical and Imaging Features of Carcinosarcoma of the Uterus and Cervix. Insights into Imaging, 12, Article No. 142. [Google Scholar] [CrossRef] [PubMed]
[15] Matsuo, K., Takazawa, Y., Ross, M.S., Elishaev, E., Podzielinski, I., Yunokawa, M., et al. (2016) Significance of Histologic Pattern of Carcinoma and Sarcoma Components on Survival Outcomes of Uterine Carcinosarcoma. Annals of Oncology, 27, 1257-1266. [Google Scholar] [CrossRef] [PubMed]
[16] Abdulfatah, E., Lordello, L., Khurram, M., Van de Vijver, K., Alosh, B., Bandyopadhyay, S., et al. (2019) Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-Institutional Study. International Journal of Gynecological Pathology, 38, 205-215. [Google Scholar] [CrossRef] [PubMed]
[17] Goyal, A., Rajshekar, S.K., Krishnappa, S., Rathod, P.S., Reddihalli, P.V., Bafna, U.D., et al. (2022) Clinico-Pathological Characteristics, Management, and Prognostic Factors of Patients with Uterine Carcinosarcoma: A Retrospective Analysis. Indian Journal of Surgical Oncology, 14, 466-472. [Google Scholar] [CrossRef] [PubMed]